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Objectives: The Oxoid M.I.C.EvaluatorTM (M.I.C.ETM; Thermo Fisher Scientiﬁc) comprises an antibiotic gradient on
a plastic support. We compared its performance with Etest
w—a similar product—using BSAC agar dilution as a
reference.
Methods: Parallel MIC tests were performed by M.I.C.Evaluator, Etest and agar dilution on Iso-SensitestTM agar.
In total, 9354 organism/strip combinations were tested by each method, using 1017 bacteria representing clini-
cally important fastidious and non-fastidious species.
Results: Essential agreement of strip MIC values (+1 doubling dilution) with the agar dilution reference, with
off-scale results excluded, was 89.9% for M.I.C.Evaluator versus 89.5% for Etest (P.0.05). These proportions
were similar, at 89.5% and 89.3% (P.0.05), respectively, if off-scale values were counted as agreeing if
they could agree (e.g. a strip MIC .32 mg/L and an agar dilution MIC of 128 mg/L). For both strips, agreement
with agar dilution was best for non-fastidious genera, Moraxella, Listeria, Pasteurella and Campylobacter spp.
and weaker for streptococci, anaerobes, Neisseria spp. and, especially, Haemophilus inﬂuenzae. Many ‘disagree-
ments’, especially for H. inﬂuenzae, concerned organisms unequivocally resistant by all methods (e.g. ampicillin
MIC 256 mg/L by agar dilution, 16 or 32 mg/L by both strips); nevertheless both strips underestimated imipe-
nem MICs for Proteus. There was no difference between the two strip types in the proportion of agreements
with agar dilution (P.0.05); nevertheless their results agreed better with each other than with agar dilution
(P,0.01).
Conclusions: The M.I.C.Evaluator performed almost identically to the Etest, giving good agreement with BSAC
agar dilution.
Keywords: susceptibility testing, sensitivity testing, antibiotic gradient strips
Introduction
Discs and automated systems with truncated MIC ranges are
adequate for most routine susceptibility testing, but precise
MIC determinations are needed in difﬁcult settings, such as
endocarditis and pneumococcal meningitis. MICs are also
needed to guide the treatment of infections caused by multire-
sistant pathogens, where pharmacodynamically based dose
adjustment may be sought. Finally, MICs are needed for organ-
isms or antibiotic/organism combinations where disc testing is
demonstrably unreliable, e.g. anaerobes, penicillin against most
a-haemolytic streptococci except pneumococci, and glycopep-
tides against Staphylococcus aureus, where diffusion tests
fail to discriminate strains with vancomycin MICs of 8 mg/L,
1
let alone those with the small reductions in susceptibility
(MICs 2–4 mg/L) now being associated with poor clinical
outcomes.
2
Classical MIC determinations on agar or in broth are routinely
performed by specialist centres, but are inconvenient for diag-
nostic laboratories, where only a few isolates require these inves-
tigations and where the range of drugs to be tested varies with
each isolate. Rather, diagnostic laboratories ﬁnd it more con-
venient to perform their few MIC tests using pre-formed anti-
biotic gradients, such as Etest
w (AB bioMe ´rieux, Marcy l’E ´toile,
France). These are versatile and give results in good agreement
with the CLSI broth microdilution method, against which they
are calibrated.
3 Their agreement with other methods, such as
that of the BSAC is less well validated, but is asserted to be
acceptable by the BSAC.
4
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1702The Oxoid M.I.C.Evaluator
TM Strip (Thermo Fisher Scientiﬁc,
Basingstoke, UK) is a new gradient strip for MIC determinations,
asserted by the manufacturer to be suitable for use on Iso-
Sensitest agar as well as Mueller–Hinton agar. We compared
its performance with that of the Etest Strip and the BSAC agar
dilution methods.
Materials and methods
Bacteria
The same 1017 bacterial strains and antibiotics were tested using
M.I.C.Evaluator Strips, Etests and the BSAC agar dilution method, with a
total of 9354 antibiotic/strain combinations. The organisms were recent
clinical isolates, selected to represent a wide range of species and sus-
ceptibilities, as summarized in Table 1. Controls comprised Escherichia
coli NCTC 10418 and ATCC
w 25922TM, Pseudomonas aeruginosa ATCC
w
27853TM, Staphylococcus aureus ATCC
w 25923TM,A T C C
w 29213TM and
ATCC
w 43300TM, Streptococcus pneumoniae ATCC
w 49619TM and ATCC
w
49620TM, Haemophilus inﬂuenzae ATCC
w 49247TM, Neisseria gonorrhoeae
ATCC
w 49226TM, Enterococcus faecalis ATCC
w 29212TM, Bacteroides fragilis
ATCC
w 25285TM and Bacteroides thetaiotaomicron ATCC
w 29741TM, all
provided as Culti-LoopsTM (Thermo Fisher Scientiﬁc).
Susceptibility tests
Tests with both the M.I.C.Evaluator and Etest Strips were performed on
Iso-Sensitest agar (Thermo Fisher Scientiﬁc) with the supplements, incu-
bation periods and conditions speciﬁed in the BSAC agar dilution method,
except that: (i) based on advice for Etests, p-nitrophenyl glycerol was
omitted from the media for strip tests with Proteeae, whereas it was
included, at 50 mg/L, as an anti-swarming agent in agar dilution MIC
determinations; and (ii) based on the package insert for the M.I.C.Evalua-
tor Strips, Iso-Sensitest agar was used throughout for tests with imipe-
nem, although the BSAC advocates Mueller–Hinton agar for this and
other carbapenems. Oxacillin strips were tested on Mueller–Hinton
agar supplemented with 2% NaCl as per the BSAC agar dilution method.
For all isolates the inocula for strip tests were matched to a 0.5 McFar-
land standard. Results were read in accordance with the manufacturers’
directions, which are essentially identical for both strip products. For bac-
tericidal antibiotics, the MIC was taken as the point of termination of all
growth; for bacteriostatic agents as the point of 80% inhibition. In those
cases where growth terminated between two points on the strip scale,
the MIC was rounded to the higher value. The following strip types
were used: 0.002–32 mg strips of ciproﬂoxacin, cefotaxime, imipenem,
levoﬂoxacin and penicillin G; 0.015–256 mg strips of amoxicillin, amoxicil-
lin/clavulanic acid, ampicillin, cefotaxime, erythromycin, gentamicin, line-
zolid, metronidazole, oxacillin, penicillin G, tetracycline and vancomycin;
and 0.06–1024 mg strips of gentamicin. Storage was at 2–88C for the
M.I.C.Evaluator Strips and 2208C for Etests. Boxes were allowed to equi-
librate at room temperature for at least 1 h before opening.
Agar dilution MICs were determined by the BSAC method, as current
in 2007,
5 on oblong 12×8 cm plates, inoculated using a 96-point inocu-
lator. Results were read with an automated optical reader (Perceptive
Instruments, Haverhill, UK) and were manually corrected as necessary.
Data handling
Data analysis was performed in Microsoft Ofﬁce Excel
w, by comparing the
number of doubling dilutions difference between each of the gradient
test strip results and the reference method. Intermediate MIC values
(1.5, 3 or 6 mg/L etc.) read from the M.I.C.Evaluator Strip or Etest
scales were rounded up to the next highest value on the standard dou-
bling dilution scale (i.e. 2, 4 or 8 mg/L) for calculations.
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JACTable 1. Continued
Enterobacteriaceae
(250)
a
Non-fermenters
(76)
b
Staphylococci
(154)
c
Enterococci
(100)
d
Streptococci
(161)
e
Neisseria
(56)
f
Haemophilus
(56)
g
Anaerobes
(101)
h
Moraxella
(10)
i
Listeria
(21)
j
Pasteurella
(10)
k
Campylo-
bacter (22)
l
Erythromycin range 0.06 to .256 0.06 to .256 1–64 0.06–0.12 0.25–4
MIC50 0.5 0.12 8 0.12 0.5
MIC90 .256 32 16 0.12 1
Gentamicin range 0.25–512 0.125 to .1024 0.016 to .1024 2 to .1024 1–64
MIC50 0.5 16 0.25 256 8
MIC90 64 .1024 32 .1024 64
Imipenem range 0.06–4 0.03 to .32 0.25–2
m 0.002–0.5 0.06–2 0.008–4
MIC50 0.25 2 1
m 0.016 0.5 0.12
MIC90 2 32 2 0.12 2 1
Levoﬂoxacin range 0.015 to .32 0.12 to .32 0.5–4 0.008–4
MIC50 0.125 0.5 1 0.015
MIC90 16 32 2 0.06
Linezolid range 0.5–32 1–64 0.5–2
MIC50 22 1
MIC90 21 6 2
Oxacillin range 0.06 to .256 0.03–16
MIC50 8 0.5
MIC90 .256 8
Penicillin G range 0.016–128 0.004–2 0.015–64 0.008 to .512 0.016–0.25
MIC50 8 0.03 0.12 4 0.12
MIC90 128 1 1 128 0.12
Tetracycline range 0.12–256 0.125–128 0.25–16 0.12–16
MIC50 0.5 0.5 0.25 0.5
MIC90 64 64 4 2
Vancomycin range 0.5–4 0.5 to .256 0.25–1
MIC50 1 8 0.5
MIC90 2 .256 0.5
Metronidazole range 0.015 to .256
MIC50 0.5
MIC90 1
aComprising 50 Citrobacter spp., 50 Enterobacter spp., 50 E. coli,5 0Klebsiella spp., 29 Proteus spp. and 21 Salmonella spp.
bComprising 26 Acinetobacter spp., 42 P. aeruginosa and 8 Pseudomonas spp.
cComprising 104 S. aureus and 50 coagulase-negative staphylococci.
dComprising 50 Enterococcus faecium,4 0E. faecalis and 10 other named Enterococcus spp.
eComprising 34 Streptococcus Lanceﬁeld A, 34 Streptococcus Lanceﬁeld B, 39 S. pneumoniae and 54 other a-haemolytic streptococci.
fComprising 27 N. gonorrhoeae and 29 Neisseria meningitidis.
gComprising 46 H. inﬂuenzae and 10 Haemophilus parainﬂuenzae.
hComprising 32 Clostridium spp., 46 Bacteroides spp., 8 Anaerococcus spp., 7 Peptoniphilus spp., 3 Finegoldia spp. 3 Peptostreptococcus spp. and 2 Parvimonas spp.
iComprising 10 Moraxella catarrhalis.
jComprising 11 Listeria monocytogenes,9Listeria innocua and 1 Listeria ivanovii.
kComprising 7 Pasteurella multocida and 3 unidentiﬁed Pasteurella spp.
lComprising 12 Campylobacter jejuni,4Campylobacter coli,5Campylobacter fetus and 1 Campylobacter lari.
mOnly E. faecalis tested.
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4‘Essential agreement’ was deﬁned as the percentage of cases where
the MIC result by the test method was within one doubling dilution of
that by the BSAC reference method among cases where both values
were on-scale.
‘Potential agreement’ was deﬁned as the percentage of cases where
the MIC result by the test method was within one doubling dilution of the
reference method or was off-scale by one method and potentially in
agreement with the reference method (e.g. .32 mg/L by one method
and 256 mg/L by the other). Either essential or potential agreement
could appear higher because the denominators and the numerators
both varied between the two measurements. Correlation between MICs
by different methods was calculated using log2 MICs, with off-scale
values excluded. Comparisons of performance were by x
2 test.
Results and discussion
Performance of M.I.C.Evaluator and Etest Strips versus
BSAC agar dilution
A total of 1017 isolates and 18 strip types were tested, with 77
antibiotic/organism combinations represented. Essential agree-
ment was achieved for 89.9% of tests with the M.I.C.Evaluator
versus 89.5% for the Etest (P.0.05) (Tables 2 and 3); potential
agreement was achieved in 89.5% for the M.I.C.Evaluator
versus 89.3% for the Etest (P.0.05) (Tables 4 and 5). The pro-
portions of strip-type/organism combinations for which various
target levels of agreement with the agar dilution reference
(≥95%, ≥90% ≥85% etc.) was achieved did not differ signiﬁ-
cantly between the two strip types (P.0.05) irrespective of the
target criterion selected (Table 6).
It should be added that these ‘global’ agreement rates
included antibiotic/organism combinations, e.g. cefotaxime and
oxacillin against MRSA and benzylpenicillin against penicillinase-
producing S. aureus, where MICs are notoriously ﬁckle and would
not ordinarily be determined. Agreement in these cases was
poorer than for most other agents tested against staphylococci,
and global agreement rates rose if they were excluded from the
analysis (Tables 2 and 4).
Even for antibiotic/organism combinations where essential
agreement was ,90%, the results of the strip tests mostly cor-
related well with BSAC agar dilution (Tables 7 and 8). Exceptions,
with poorer correlation (r≤0.7), were: (i) imipenem against
Enterobacteriaceae, where a distortion arose owing to the
behaviour of Proteeae, as described below; (ii) cases where
high-drug-content strips were tested against species groups
where low-content strips were more appropriate, as with cefo-
taxime against Neisseria spp.; and (iii)—most especially—(Tables
7 and 8), cases where MICs by the reference method were clus-
tered over four or fewer drug dilutions, i.e. over a scarcely wider
collective range than the+1 doubling dilution range convention-
ally accepted as experimental variation when the MIC for a single
organism is repeatedly determined by the same method.
In general, agreement between the two strip tests and the
BSAC reference method was best for non-fastidious organisms,
including staphylococci, enterococci, Enterobacteriaceae and
non-fermenters, and for members of the genera Moraxella, Lis-
teria, Pasteurella and Campylobacter (Tables 2–5). For these
organisms, and taking all antibiotics combined, there was
.89% essential agreement with the BSAC reference for the
Table 2. ‘Essential agreement’ (%) between M.I.C.Evaluator (M.I.C.E) or Etest and agar dilution (+1 doubling dilution*), counting only on-scale
values: non-fastidious species
Enterobacteriaceae Non-fermenters Staphylococci Enterococci
M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest
Amoxicillin/clavulanic acid 86.9 91.3
Amoxicillin 87.3 88.7
Ampicillin 87.6 87.6 77.3 81.8
Cefotaxime 32 92.7 87.6 98* 83*
Cefotaxime 256 91.1 85.8 80.7* 99.1*
Ciproﬂoxacin 95.8 96.2 100 100 98.9 98.9
Erythromycin 93.7 98.9
Gentamicin 256 91.6 93.6 93.5 93.5 96 95.3
Gentamicin 1024 94.9 91.8 95.3 93.8 95.6 96.4 88.1 82.1
Imipenem 81.7 82.5 96 88 95.1
a 82.9
a
Levoﬂoxacin 94.3 92.1 98 99
Linezolid 99.3 99.3 94.2 96.1
Oxacillin 83.2* 74.7*
Penicillin G 32 87.2* 80.2*
Penicillin G 256 83.9* 83*
Tetracycline 98.7 98.7
Vancomycin 95.6 96.2 93.3 93.3
Overall 90.4 89.7 96.2 93.8 93.0 92.5 89.6 87.2
Excluding asterisked values 97.0 97.8
aOnly E. faecalis tested.
M.I.C.Evaluator and Etest versus BSAC MIC tests
1705
JACTable 4. ‘Potential agreement’ (%) between M.I.C.Evaluator (M.I.C.E) or Etest Strips and agar dilution (+1 doubling dilution*), counting all potential
agreements as agreement: non-fastidious species
Enterobacteriaceae Non-fermenters Staphylococci Enterococci
M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest
Amoxicillin/clavulanic acid 78.3 83.7
Amoxicillin 91.1 91.1
Ampicillin 89.1 89.1 70.5 79.4
Cefotaxime 32 89.9 84.1 94.3* 82.3*
Cefotaxime 256 89.1 84.8 77.9* 94.9*
Ciproﬂoxacin 95.7 94.1 98.7 98.7 95.6 95.6
Erythromycin 98.7 99.3
Gentamicin 256 91.4 93 94.8 93.5 96.2 94.3
Gentamicin 1024 94.9 91.8 94.8 94.8 95.5 96.2 87.2 83.3
Imipenem 81.7 82.5 85.8 73 95.1
b 82.9
b
Levoﬂoxacin 88.3 84.5 75
a 75.6
a
Linezolid 99.3 99.3 94.2 96.1
Oxacillin 82.5* 76.8*
Penicillin G 32 86.7* 81.7*
Penicillin G 256 79.2* 77.9*
Tetracycline 98.1 98.7
Vancomycin 95.6 96.2 93.1 93.1
Overall 89.0 87.9 93.5 90.0 90.4 89.9 88.0 86.7
Excluding asterisked values 94.3 94.4
aPoorer potential than essential agreement (see Table 2) for levoﬂoxacin versus staphylococci reﬂects 25 isolates with MICs of 16 mg/L by agar
dilution, but .32 mg/L by both strip methods.
bOnly E. faecalis tested.
Table 3. ‘Essential agreement’ (%) between M.I.C.Evaluator (M.I.C.E) or Etest and agar dilution (+1 doubling dilution), counting only on-scale
values: fastidious species
Streptococci Neisseria Haemophilus Anaerobes Moraxella Listeria Pasteurella Campylobacter
M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest
Amoxicillin/
clavulanic acid
73.8 65 88 91.7 100 100
Amoxicillin 92.7 84.1 59.4 42.4
Ampicillin 94.2 94.2 83.9 85.7 73.8 60.5 95.2 100
Cefotaxime 32 92 88.3 78.2 78.2 83.7 55.8
Cefotaxime 256 88.3 82.1 57.1 71.4 68.8 85.7
Ciproﬂoxacin 96.2 95.5 98 98 59.5 88 100 100
Erythromycin 60.9 66.2 97.6 95.2 100 95.4 90.9 90.9
Gentamicin 256 88.9 93.2
Gentamicin 1024 81.6 94.4
Imipenem 95 65 54.8 58 46.5 48.8
Levoﬂoxacin 97.5 96.9 100 97.7
Linezolid 98.1 98.7
Oxacillin 89.5 71.1
Penicillin G 32 61.9 68 72.7 89 88 89.1 100 100
Penicillin G 256 63.8 74.3 80.3 80.3 92 90.9 90 90
Tetracycline 76.6 76.6 98.2 96.4 97.7 95.4
Vancomycin 73 77.9
Metronidazole 84.1 81.3
Overall 84.4 82.9 81.2 85.6 76.9 74.4 79.7 80.4 100 100 97.6 97.7 95.0 95.0 95.5 95.5
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1706M.I.C.Evaluator Strips and .87% for Etest Strips. Essential agree-
ment was less good, at between 83% and 88% for all antibiotics
combined, for anaerobes, Neisseria spp. and Streptococcus spp.
and poorest, at 72.7%–75.9%, for H. inﬂuenzae. Agreement
rates for H. inﬂuenzae were lowered by imipenem (which would
rarely be tested against the species) and, more importantly, by
amoxicillin and ampicillin. Many of the underlying disagreements
with these latter drugs were for b-lactamase-positive isolates
found highly resistant by all methods, but with substantially
higher MICs by one method than another (e.g. agar dilution
amoxicillin MIC 256 mg/L, but only 32 mg/L by the strip
methods). MICs are rarely determined for such unequivocal
isolates in clinical practice. Among amoxicillin-borderline
H. inﬂuenzae isolates—where strip tests are more likely to be
used—four of seven with amoxicillin MICs of 1 mg/L by agar
dilution (i.e. just susceptible) were found susceptible using both
strip types, with MICs of 0.5–1 mg/L, whereas three proved
resistant, with MICs of 1.5–2 mg/L; among ﬁve with agar dilution
MICs of 2–4 mg/L (i.e. just resistant), one was found susceptible to
amoxicillin with both strip types, with MICs of 0.5–1 mg/L, one
was resistant, with MICs of 8 mg/L (Etest) and 16 mg/L (M.I.C.Eva-
luator) and three gave mixed results, with MICs of 1 mg/Lwith one
strip and 1.5 mg/L with the other. Tristram
6 similarly tested M.I.C.
Evaluator ampicillin strips against H. inﬂuenzae, though taking
CLSI broth microdilution as a reference, and found 90% agree-
ment (+1 doubling dilution) for ampicillin-susceptible isolates
and those with b-lactamase-negative ampicillin resistance,
versus only 65%–75% for those with b-lactamase.
Tests with penicillin against streptococci also deserve
comment, being another case where gradient MIC test strips are
particularly useful—e.g. for pneumococci with borderline resist-
ance and for endocarditis isolates—but where agreement
appeared rather low, at 62%–68%. These ﬁgures, however, exag-
gerate the ‘disagreements’, which largely concerned b-haemolytic
streptococci with penicillin MICs of ≤0.008 mg/L by agar dilution
and 0.023 (rounded to 0.03) mg/L by the strip methods—a differ-
ence of no practical consequence. Penicillin MICs by Etest and
M.I.C.Evaluator Strips for pneumococci with agar dilution MICs
from 0.12 to 2 mg/L are shown in Table 9, indicating perfect
essential agreement for the two high-content strips, though
rather poorer for the low-content M.I.C.Evaluator Strip.
Agreement rates for Enterobacteriaceae were poorer with imi-
penem than with other strip types. This was largely owing to the
strips giving  8-fold lower imipenem MICs for Proteus spp.
Table 5. ‘Potential agreement’ (%) between M.I.C.Evaluator (M.I.C.E) or Etest Strips and agar dilution (+1 doubling dilution), counting all potential
agreements as agreement: fastidious species
Streptococci Neisseria Haemophilus Anaerobes Moraxella Listeria Pasteurella Campylobacter
M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest
Amoxicillin/
clavulanic acid
72 62.7 88.1 91.8 100 100
Amoxicillin 93.2 85.2 56.8 43
Ampicillin 94.4 94.4 83.9 85.7 72.1 55.8 95.4 100
Cefotaxime 32 92 88.3 82.1 82.1 83.7 55.8
Cefotaxime 256 92 88.3 82.1 87.5 76.7 88.3
Ciproﬂoxacin 94.4 93.2 94.6 94.6 58.1 86 90.9 100
Erythromycin 63.1 68 97.6 93 100 95.4 90.9 90.9
Gentamicin 256 88.9 93.2
Gentamicin 1024 81.6 94.4
Imipenem 95 65 46.5 48.8 69 69
Levoﬂoxacin 97.5 96.9 97.7 97.7
Linezolid 98.1 98.7
Oxacillin 89.5 71.1
Penicillin G 32 61.9 68 73.2 89.2 84.5 89 100 100
Penicillin G 256 63.8 74.8 80.3 80.3 91.8 90 90.9 90.9
Tetracycline 76.6 76.6 98.2 96.4 97.7 95.4
Vancomycin 73 77.9
Metronidazole 84.5 81.8
Overall 84.7 83.4 84.9 88.0 75.9 72.7 83.6 84.3 100 100 97.7 97.7 95.5 95.5 90.9 95.5
Table 6. Agreement of MICs by strip methods with BSAC agar dilution,
based on 77 strip/organism combinations
No. (out of 77 combinations)
with essential agreement
No. (out of 77 combinations)
with potential agreement
M.I.C.Evaluator Etest P M.I.C.Evaluator Etest P
≥95% 28 25 .0.05 21 18 .0.05
≥90% 42 39 .0.05 39 38 .0.05
≥85% 52 50 .0.05 49 48 .0.05
≥80% 61 61 .0.05 59 59 .0.05
≥75% 64 64 .0.05 65 66 .0.05
≥70% 68 68 .0.05 70 68 .0.05
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Enterobacteriaceae Non-fermenters Staphylococci Enterococci
M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest
Amoxicillin/clavulanic acid 0.949 0.891
Amoxicillin 0.927 0.94
Ampicillin 0.906 0.898 0.962 0.921
Cefotaxime 32 0.951 0.939 0.906 0.913
Cefotaxime 256 0.962 0.957 1 1
Ciproﬂoxacin 0.924 0.916 0.972 0.971 0.871 0.888
Erythromycin 0.906 0.911
Gentamicin 256 0.939 0.916 0.946 0.944 1 1
Gentamicin 1024 0.957 0.949 0.964 0.961 0.977 0.979 0.933 0.911
Imipenem 0.562
a 0.427
a 0.951 0.922 0.553 0.446
Levoﬂoxacin 0.951 0.951 0.95 0.95
Linezolid 0.9 0.9 0.947 0.941
Oxacillin 0.907 0.906
Penicillin G 32 0.9 0.9
Penicillin G 256 0.958 0.958
Tetracycline 0.962 0.975
Vancomycin 0.655
b 0.7 0.955 0.969
Overall 0.903 0.878 0.958 0.949 0.915 0.921 0.870 0.837
M.I.C.E, M.I.C.Evaluator.
aMost of the less-susceptible organisms were Proteeae, for which there was poor correlation between BSAC and strip methods.
bPoor correlation (≤0.7) explained by .90% agar dilution MICs being spread over ≤4 dilutions.
Table 8. Correlation coefﬁcients between MICs determined by strip methods and those found by BSAC agar dilution: fastidious species
Streptococci Neisseria Haemophilus Anaerobes Moraxella Listeria Pasteurella Campylobacter
M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest M.I.C.E Etest
Amoxicillin/
clavulanic acid
0.7 0.6 0.9 0.9 0.9 0.939
Amoxicillin 0.926 0.915 0.762 0.653
Ampicillin 0.937 0.942 0.9 0.9 0.895 0.853 0.132
a 0.311
a
Cefotaxime 32 0.9 0.9 0.655 0.717 0.9 0.9
Cefotaxime 256 0.9 0.9 0.5 0.6 0.8 0.9
Ciproﬂoxacin 0.78 0.757 0.920 0.939 0.6
a 0.6
a 0.931 0.95
Erythromycin 0.763 0.838 0.9 0.9 0.445
a 0.488
a 0.681
a 0.677
a
Gentamicin 256 0.707 0.719
Gentamicin 1024 0.703 0.763
Imipenem 0.989 0.991 0.7
a 0.6
a 0.793 0.724
Levoﬂoxacin 0.522
a 0.47
a 0.9 0.9
Linezolid 0.656
a 0.654
a
Oxacillin 0.916 0.934
Penicillin G 32 0.9 0.9 0.917 0.916 0.946 0.939 0.936 0.948
Penicillin G 256 0.9 0.9 0.930 0.938 0.946 0.95 0.798 0.867
Tetracycline 0.919 0.958 0.9 0.9 0.949 0.928
Vancomycin 0.285
a 0.386
a
Metronidazole 0.56 0.5
Overall 0.8 0.808 0.817 0.844 0.811 0.763 0.829 0.803 0.9 0.939 0.288 0.399 0.867 0.907 0.806 0.813
M.I.C.E, M.I.C.Evaluator.
aPoor correlation (≤0.7) explained by .90% agar dilution MICs being spread over ≤4 dilutions.
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metric mean MIC values (Table 10); these are a valid summary
parametersincetheMICswerenormallydistributedandunimodal
within eachspecies. It is possible that higher MICs byagardilution
for Proteeae reﬂected the inclusion of p-nitrophenyl glycerol to
prevent swarming, but we can ﬁnd no published assertion that
thiscompoundinterfereswiththeactivityofimipenem;moreover,
broth dilution MICs, e.g. by the CLSI method, are similarly high for
Proteusspp. withno anti-swarming agentpresent.
7An alternative
explanation,perhapsmorelikely,issimplythatinseekingtoignore
swarming into the zone of inhibition, the recorder tends to under-
estimate the real MICs.
Other speciﬁc concerns could be identiﬁed, e.g. there were 19
enterococci with gentamicin MICs of 256–512 mg/L, counting as
high-level resistant by BSAC criteria, but nine of these gave MICs
≤128 mg/L by Etest, counting as susceptible, and ﬁve did so by
M.I.C.Evaluator. Only 2/34 enterococci with gentamicin MICs of
≥1024 mg/L gave MICs ≤128 mg/L by the strip methods, each
of them with both products, whilst 2/51 enterococci with a gen-
tamicin MIC ≤128 mg/L by agar dilution appeared resistant, with
MICs ≥256 mg/L in strip tests, one with the Etest only and one
with both products.
Agreement between M.I.C.Evaluator and Etest Strip
results
Concordance between the M.I.C.Evaluator Strip and Etest Strip
results was excellent, with .95% potential agreement (+1
dilution) for 54 of 77 strip/organism combinations and 90%–
95% for another 12 (Table 11). These proportions are signiﬁcantly
better than between either strip type and agar dilution (P,0.01,
x
2 test; compare Table 6). The only antibiotic/organism combi-
nations with ,85% agreement between the two strips were
amoxicillin/clavulanic acid against both Enterobacteriaceae
(70.6%) and Haemophilus spp. (81.3%) and both ampicillin and
amoxicillin against Haemophilus spp. (67.4% and 68.1%,
respectively). In the case of ampicillin and amoxicillin, virtually
Table 9. Strip MICs for pneumococci with agar dilution penicillin MICs of 0.125–2 mg/L
Agar Etest M.I.C.Evaluator
penicillin G penicillin G 32 penicillin G 256 penicillin G 32 penicillin G 256
H051360048 0.125 0.125 0.125 0.125 0.125
H014200026 0.25 0.25 0.38 0.38 0.38
H051380053 1 1.5 1.5 1.5 1
H051440589 1 2 1.5 1.5 1.5
H051460137 1 0.75 0.75 2 1
H051380039 1 0.75 1 1 0.75
H050300113 1 1.5 1.5 1 1
PN2940 1 0.75 0.75 1 1
H040440029 1 3
a 2 4
a 2
H051440587 1 1 1.5 2 1
H050720467 1 2 1.5 2 1.5
H059200073 1 1 1.5 3
a 1.5
H051240370 1 2 1.5 3
a 1.5
H050420065 1 1 1.5 1.5 1.5
H045200156 1 1.5 1.5 3
a 0.5
PN2177 2 3 3 4
a 3
a
H040440026 2 1 1.5 1.5 1
H050480159 2 2 2 3
a 2
PN1847 2 1.5 2 16
a 3
a
H051240093 2 2 1.5 3
a 1.5
H050440059 2 2 2 3
a 2
H045240059 2 2 1.5 2 1.5
Essential agreement with reference (%) – 95.5 100 77.3 100
Bold font indicates MIC disagreement of .1 doubling dilution.
aCategorization difference versus breakpoints of: susceptible, ≤0.06 mg/L; and resistant, .2 mg/L.
Table 10. Geometric mean MICs (mg/L) of imipenem for
Enterobacteriaceae genera
Agar dilution Etest M.I.C.Evaluator
Citrobacter spp. 0.44 0.32 0.23
Enterobacter spp. 0.42 0.61 0.36
E. coli 0.15 0.23 0.15
Klebsiella spp. 0.40 0.34 0.23
Proteus spp. 1.73 0.27 0.29
Salmonella spp. 0.37 0.31 0.22
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resistant by all three methods, while most (43/75) .1 dilution
disagreements for amoxicillin/clavulanic acid against Enterobac-
teriaceae related to Enterobacter and Citrobacter spp., both of
which are inherently resistant to the drug combination.
Conclusions
Etests are in widespread use for custom MIC determinations in
diagnostic laboratories. They have been calibrated to give equiv-
alent MICs to those found by CLSI methodology using Mueller–
Hinton agar, and there is a voluminous literature to support
their accuracy when used in this manner.
3 The manufacturer
(AB Biodisk at the time of this study, now bioMe ´rieux) does not
advocate their use on other media, and there are no substantial
performance studies on Iso-Sensitest agar, which is the standard
medium for the BSAC dilution method. The BSAC nevertheless
states that, in general, Etests can be used on Iso-Sensitest
agar, with BSAC/EUCAST breakpoints, so long as inocula equival-
ent to a 0.5 McFarland are used.
4
The M.I.C.Evaluator Strip has been developed as an alternative
strip-based MIC method, which the manufacturer indicates to be
suitable for use on either Mueller–Hinton or Iso-Sensitest agar.
As with the Etest Strip, it comprises a laminated plastic
support carrying a double series of antibiotic-impregnated dro-
plets of diminishing content. Once placed on agar, the strip
rapidly releases the antibiotic, delivering a stable gradient.
After incubation, the MIC can be read off against a printed
scale. The present data show that, used on Iso-Sensitest agar,
both M.I.C.Evaluator and Etest Strips gave essentially equivalent
results to one another and acceptable agreement with BSAC agar
dilution.
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